Biosimilars Poll: What is Your Opinion on Clinical Efficacy Trials?

October 12, 2020

There are diverging opinions on whether comparative efficacy trials add much of value to the evidence for biosimilar approval in the United States.

Take the Biosimilars Poll!

There are diverging opinions on whether comparative efficacy trials add much of value to the evidence for biosimilar approval in the United States.

Which of the following best describes your opinion?

Check out the results from our last poll: